TGA Approval

ORALAIR ContinuationTreatment Sublingual (Allergen pollen Extract of 5 grasses) Tablets 300IR blister pack (167566)

ARTG ID

167566

ARTG Name

ORALAIR ContinuationTreatment Sublingual (Allergen pollen Extract of 5 grasses) Tablets 300IR blister pack

Sponsor

Stallergenes Australia Pty Ltd

ARTG Date

May 3, 2011

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Stallergenes Australia Pty Ltd

Sponsor Item Name

STALLERGENES AUSTRALIA PTY LTD

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/9f76c4584cc62c206c615f6e99c35e6c.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/a69463fd3d4699f3594b8bb1f97df663.pdf

Active Ingredients

Ingredient Name

Anthoxanthum odoratum

Ingredient Name

Dactylis glomerata

Ingredient Name

Lolium perenne

Ingredient Name

Phleum pratense

Ingredient Name

Poa pratensis

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

AI-Powered Research

Premium Access

ORALAIR ContinuationTreatment Sublingual (Allergen pollen Extract of 5 grasses) Tablets 300IR blister pack (167566)

Sponsor Information

Product Information

Consumer Medicine Information

Product Information

Active Ingredients

MedPath

Product

Company

Legal